Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Aileron Therapeutics (ALRN) Earnings Date, Estimates & Call Transcripts

Aileron Therapeutics logo

Aileron Therapeutics Earnings Summary

Latest Q2
Earnings Date
Aug. 14Estimated
Consensus EPS
(Aug. 14)
-$0.25
Actual EPS
(Aug. 14)
-$0.45 Missed By -$0.20

Aileron Therapeutics issued Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.45, which missed the consensus estimate of -$0.25 by $0.20. With a trailing EPS of -$3.12, Aileron Therapeutics' earnings are expected to grow next year, from ($1.56) to ($1.41) per share.

Q2 2024 Earnings Resources

Get Aileron Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aileron Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aileron Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.56) EPS
Next Year EPS Consensus Estimate
($1.41) EPS

Aileron Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2024--$0.25-$0.45 -$0.20-$0.45--
5/20/2024--$0.14-$0.86 -$0.72-$0.86--
4/15/2024Q4 2023--$1.54 -$1.54-$1.54--
10/13/2023Q3 2023--$0.40 -$0.40-$0.40--
8/11/2023Q2 2023--$0.39 -$0.39-$0.39--
5/8/2023Q1 2023--$0.82 -$0.82-$0.59--

Aileron Therapeutics Earnings - Frequently Asked Questions

Aileron Therapeutics (NASDAQ:ALRN) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on ALRN's earnings history.

In the previous quarter, Aileron Therapeutics (NASDAQ:ALRN) missed the analysts' consensus estimate of ($0.25) by $0.20 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. ALRN's actual earnings.

Aileron Therapeutics (NASDAQ:ALRN) has a recorded net income of -$15.73 million. ALRN has generated -$3.12 earnings per share over the last four quarters.

Aileron Therapeutics's earnings are expected to grow from ($1.56) per share to ($1.41) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ALRN) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners